Search

everythinglearnresearchcommunity

for

Search:↓

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

COVID-19 may cause hair loss due to infection stress or treatments.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

AGA linked to worse COVID-19 outcomes in men.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Hair loss doesn't affect COVID-19 severity.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

The pandemic changed how often certain skin conditions were diagnosed.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.